Miura Global Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,000
Closed -$1.77M 28
2024
Q3
$1.77M Sell
2,000
-3,500
-64% -$3.15M 2.03% 14
2024
Q2
$4.98M Sell
5,500
-1,500
-21% -$1.2M 4.86% 6
2024
Q1
$5.45M Sell
7,000
-9,000
-56% -$6.41M 4.64% 8
2023
Q4
$9.33M Buy
16,000
+1,000
+7% +$584K 5.22% 7
2023
Q3
$8.06M Hold
15,000
5.51% 7
2023
Q2
$7.03M Buy
+15,000
New +$6.29M 2.51% 12

Other funds holding LLY

Miura Global Management's LLY Position: Q4 2024 in Review

Miura Global Management sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 2,000 shares — an estimated $1.77M sold.

Miura Global Management first reported a position in LLY in Q2 2023 and held it in 6 quarters. The position peaked at $9.33M in Q4 2023. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Miura Global Management reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Miura Global Management sold 2,000 Eli Lilly shares in Q4 2024, an estimated $1.77M.
  • Miura Global Management first reported a position in Eli Lilly in Q2 2023 and held it in 6 quarters.
  • Miura Global Management's Eli Lilly position peaked at $9.33M in Q4 2023.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Miura Global Management's 13F filing for Q4 2024, filed 14 Feb 2025.